Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

EU regulator verdict on Moderna COVID-19 booster shot next week

Stock MarketsOct 21, 2021 11:36AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. FILE PHOTO: A vial of the Moderna COVID-19 vaccine is seen at a local clinic as the spread of the coronavirus disease continues in Aschaffenburg, Germany, January 15, 2021. REUTERS/Kai Pfaffenbach

LONDON (Reuters) - The European Union's drug regulator expects to announce the results of its review of Moderna (NASDAQ:MRNA)'s COVID-19 booster vaccine next week and also to start a rolling review of Merck's antiviral oral pill, a senior official said on Thursday.

The results of the Moderna review will be announced on Oct. 25, Marco Cavaleri, head of vaccines strategy for the European Medicines Agency (EMA), told a briefing.

Cavaleri also said it was not clear whether Russia would submit an application for its one-dose coronavirus vaccine, known as Sputnik Light, in addition to one already submitted for its two-dose Sputnik V shot.

"We don't have really any clear understanding of whether (the Russian team) intends to submit an application also for this vaccine in the European Union, but we will continue the dialogue to get more clarity on this," he said.

The start of a formal review of the two-dose Sputnik V was confirmed in March, but no decision has yet been announced.

Reuters reported on Thursday that the regulator was unlikely to decide whether to approve the Russian vaccine until at least the first quarter of 2022 because it still lacked some data required for the review.

This is in line with what the World Health Organization has said regarding delays in its Emergency Use Listing process.


The EMA's conclusion on boosters of Moderna's vaccine, Spikevax, is expected for use in people over 12 years of age and the shot is to be given six months after a second dose.

The EMA said it expected to receive data on boosters of the single-shot Johnson & Johnson (NYSE:JNJ) vaccine in the coming weeks.

On Oct. 4, the watchdog gave the go-ahead for the Pfizer-BioNTech boosters and recommended a third dose of a shot from Pfizer-BioNTech or Moderna for vulnerable people, leaving it to member states to decide for the rest.

U.S. authorities have authorised on Wednesday booster doses of Pfizer-BioNTech, Moderna and J&J.

While vaccines are the main weapon against COVID-19, Merck's experimental pill, which it is developing with partner Ridgeback Biotherapeutics, could be a game-changer after studies showed it could halve the chances of dying or being hospitalised for those most at risk of contracting severe illness.

Britain has already secured a deal for the drug, molnupiravir, well before any approvals.

EU regulator verdict on Moderna COVID-19 booster shot next week

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email